LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220K904. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,366,176 | +24.7% | 22,800 | +50.0% | 0.01% | +25.0% |
| Q2 2023 | $1,095,920 | +47.5% | 15,200 | +50.5% | 0.00% | +33.3% |
| Q1 2023 | $742,956 | +11.2% | 10,100 | +1.0% | 0.00% | +50.0% |
| Q4 2022 | $668,000 | -22.4% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $861,000 | -4.4% | 10,000 | -1.0% | 0.00% | +100.0% |
| Q2 2022 | $901,000 | -20.7% | 10,100 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,136,000 | -43.8% | 10,100 | -22.9% | 0.00% | -50.0% |
| Q4 2021 | $2,023,000 | -32.1% | 13,100 | -38.8% | 0.00% | -33.3% |
| Q3 2021 | $2,981,000 | +5.7% | 21,400 | -0.5% | 0.00% | 0.0% |
| Q2 2021 | $2,821,000 | -71.7% | 21,500 | -67.2% | 0.00% | -80.0% |
| Q1 2021 | $9,985,000 | +143.1% | 65,500 | +58.6% | 0.02% | +114.3% |
| Q4 2020 | $4,107,000 | +183.4% | 41,300 | +171.7% | 0.01% | +40.0% |
| Q3 2020 | $1,449,000 | -84.7% | 15,200 | -82.1% | 0.01% | -88.6% |
| Q2 2020 | $9,496,000 | +18.1% | 84,900 | -23.2% | 0.04% | -32.3% |
| Q1 2020 | $8,043,000 | -61.5% | 110,600 | -44.8% | 0.06% | -54.2% |
| Q4 2019 | $20,879,000 | +135.9% | 200,200 | +125.2% | 0.14% | +100.0% |
| Q3 2019 | $8,849,000 | +5.5% | 88,900 | +21.0% | 0.07% | -6.6% |
| Q2 2019 | $8,390,000 | +16.5% | 73,500 | +28.3% | 0.08% | -5.0% |
| Q1 2019 | $7,203,000 | +342.4% | 57,300 | +377.5% | 0.08% | +471.4% |
| Q4 2018 | $1,628,000 | +158.0% | 12,000 | +421.7% | 0.01% | +180.0% |
| Q3 2018 | $631,000 | +8.8% | 2,300 | -17.9% | 0.01% | 0.0% |
| Q2 2018 | $580,000 | +778.8% | 2,800 | +600.0% | 0.01% | +400.0% |
| Q1 2018 | $66,000 | -62.9% | 400 | -69.2% | 0.00% | 0.0% |
| Q4 2017 | $178,000 | +334.1% | 1,300 | +333.3% | 0.00% | – |
| Q3 2017 | $41,000 | -98.2% | 300 | -98.4% | 0.00% | -100.0% |
| Q2 2017 | $2,307,000 | +988.2% | 19,000 | +850.0% | 0.02% | +1100.0% |
| Q1 2017 | $212,000 | -0.5% | 2,000 | -4.8% | 0.00% | 0.0% |
| Q4 2016 | $213,000 | +2030.0% | 2,100 | +2000.0% | 0.00% | – |
| Q3 2016 | $10,000 | -83.3% | 100 | -80.0% | 0.00% | -100.0% |
| Q2 2016 | $60,000 | +185.7% | 500 | +150.0% | 0.00% | – |
| Q1 2016 | $21,000 | -4.5% | 200 | 0.0% | 0.00% | – |
| Q4 2015 | $22,000 | -80.2% | 200 | -84.6% | 0.00% | -100.0% |
| Q3 2015 | $111,000 | -95.5% | 1,300 | -94.7% | 0.00% | -94.3% |
| Q2 2015 | $2,492,000 | +688.6% | 24,700 | +502.4% | 0.04% | +600.0% |
| Q1 2015 | $316,000 | +12.1% | 4,100 | -22.6% | 0.01% | +25.0% |
| Q4 2014 | $282,000 | -41.2% | 5,300 | -31.2% | 0.00% | -42.9% |
| Q2 2014 | $480,000 | -6.1% | 7,700 | +1.3% | 0.01% | -22.2% |
| Q1 2014 | $511,000 | -63.1% | 7,600 | -71.1% | 0.01% | -57.1% |
| Q4 2013 | $1,383,000 | +111.5% | 26,300 | +74.2% | 0.02% | +61.5% |
| Q3 2013 | $654,000 | -25.3% | 15,100 | -35.5% | 0.01% | -40.9% |
| Q2 2013 | $876,000 | – | 23,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 10,100 | $901,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1,000 | $89,000 | 0.00% |
| JPMORGAN CHASE & CO | 4,000 | $357,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |